Immix Biopharma, Inc.
USD9.57
+0.77 (+8.75%)
CEO
Ilya Rachman
IPO Date
2021-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.88
Prev. Close
$8.80
Day Low
$8.83
Day High
$9.69
52W Low
$1.94
52W High
$12.14
Market Cap
$0.52B
Volume
2.48M
| 12,500 |
| $8.78 |
| 29 May 2026 | Ng Carey | director | A-Award | Acquired | 6,250 | $0.00 |
| 29 May 2026 | Ng Carey | director | A-Award | Acquired | 12,500 | $8.78 |
| 29 May 2026 | Marquet Magda | director | A-Award | Acquired | 6,250 | $0.00 |
| 29 May 2026 | Marquet Magda | director | A-Award | Acquired | 12,500 | $8.78 |
| 29 May 2026 | Morris Gabriel S | director, officer: CFO, President | A-Award | Acquired | 500,000 | $8.78 |
| 29 May 2026 | CHANG NANCY T | director | A-Award | Acquired | 6,250 | $0.00 |
| 29 May 2026 | CHANG NANCY T | director | A-Award | Acquired | 12,500 | $8.78 |
| 29 May 2026 | Rachman Ilya M | director, officer: CEO and Chairman | A-Award | Acquired | 500,000 | $8.78 |